Other tests are also useful in identifying cancer-causing targets, such as whole exome sequencing for RASGRF1 fusion and RICTOR amplification, whole-transcriptome sequencing for CLIP1-LTK fusion, and RNA sequencing for LINE-1-FGGY. Here, LTK is linked to cancer.